Astrana Health (ASTH) Equity Income (2017 - 2025)
Astrana Health (ASTH) has disclosed Equity Income for 9 consecutive years, with $1.2 million as the latest value for Q4 2025.
- Quarterly Equity Income fell 24.18% to $1.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.7 million through Dec 2025, down 61.9% year-over-year, with the annual reading at $1.7 million for FY2025, 61.63% down from the prior year.
- Equity Income hit $1.2 million in Q4 2025 for Astrana Health, up from $1.0 million in the prior quarter.
- In the past five years, Equity Income ranged from a high of $6.0 million in Q3 2021 to a low of -$3.1 million in Q2 2021.
- Historically, Equity Income has averaged $1.0 million across 5 years, with a median of $1.2 million in 2022.
- Biggest five-year swings in Equity Income: tumbled 475.78% in 2021 and later soared 311.67% in 2022.
- Year by year, Equity Income stood at $6.0 million in 2021, then plummeted by 79.6% to $1.2 million in 2022, then skyrocketed by 102.04% to $2.5 million in 2023, then tumbled by 37.33% to $1.6 million in 2024, then decreased by 24.18% to $1.2 million in 2025.
- Business Quant data shows Equity Income for ASTH at $1.2 million in Q4 2025, $1.0 million in Q3 2025, and $381000.0 in Q2 2025.